XML 34 R18.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Shareholders' Equity and Share-Based Compensation | 12 Months Ended
--- | ---
Dec. 26, 2024
Equity [Abstract] |
Shareholders’ Equity and Share-Based Compensation | 8. Shareholders’ Equity and Share-Based Compensation Shareholders may convert their shares of Class B Common Stock into shares of Common Stock at any time. Class B Common Stock shareholders are substantially restricted in their ability to transfer their Class B Common Stock. Holders of Common Stock are entitled to cash dividends per share equal to 110% of all dividends declared and paid on each share of the Class B Common Stock. Holders of Class B Common Stock are entitled to ten votes per share while holders of Common Stock are entitled to one vote per share on any matters brought before the shareholders of the Company. Liquidation rights are the same for both classes of stock. Through December 26, 2024, the Company’s Board of Directors has approved the repurchase of up to 11,687,500 shares of Common Stock to be held in treasury. The Company intends to reissue these shares upon the exercise of stock options and the issuance of restricted stock, restricted stock units and performance stock units. The Company repurchased 713,456, 94,508 and 134,694 shares pursuant to these authorizations during fiscal 2024, fiscal 2023 and fiscal 2022, respectively. At December 26, 2024, there were 1,714,682 shares available for repurchase under these authorizations. In fiscal 2024, the Company discontinued its Associate Stock Purchase Plan and amended its Dividend Reinvestment Plan. Under the amended plan, the Company’s Board of Directors has authorized the issuance of up to 250,000 shares of Common Stock. At December 26, 2024, there were 245,330 shares available under this authorization. Shareholders have approved the issuance of up to 7,437,500 shares of Common Stock under various equity incentive plans. At December 26, 2024, there were 159,370 shares available for grants of various equity awards under the current plan, each discussed below. Total pre-tax share-based compensation expense was $8,206, $6,394 and $8,170 in fiscal 2024, fiscal 2023 and fiscal 2022, respectively. The recognized tax benefit on share-based compensation was $1,879, $1,000 and $1,338 in fiscal 2024, fiscal 2023 and fiscal 2022, respectively. Stock Options Stock options granted under the plans to employees generally become exercisable either 40% after two years, 60% after three years, 80% after four years and 100% after five years of the date of grant, or 50% after two years, 75% after three years and 100% after four years of the date of grant, depending on the date of grant. The options generally expire ten years from the date of grant as long as the optionee is still employed with the Company. The Company ceased issuing stock options beginning in fiscal 2024. A summary of the Company’s stock option activity and related information follows (shares in thousands):
| Year Ended
| December 26, 2024 |  | December 28, 2023 |  | December 29, 2022
| Options |  | Weighted- Average Exercise Price |  | Options |  | Weighted- Average Exercise Price |  | Options |  | Weighted- Average Exercise Price
Outstanding at beginning of period | 3,173 |  |  | $ | 22.69 |  |  | 2,866 |  |  | $ | 23.76 |  |  | 2,533 |  |  | $ | 24.84 |
Granted | — |  |  | — |  |  | 525 |  |  | 15.96 |  |  | 501 |  |  | 16.99 |
Exercised | (129) |  |  | 15.34 |  |  | (83) |  |  | 13.05 |  |  | (68) |  |  | 13.15 |
Forfeited | (160) |  |  | 18.94 |  |  | (135) |  |  | 25.11 |  |  | (100) |  |  | 24.89 |
Outstanding at end of period | 2,884 |  |  | 23.22 |  |  | 3,173 |  |  | 22.69 |  |  | 2,866 |  |  | 23.76 |
Exercisable at end of period | 2,125 |  |  | $ | 25.48 |  |  | 1,989 |  |  | $ | 25.53 |  |  | 1,613 |  |  | $ | 25.70 |
Weighted-average fair value of options granted during the period | n/a |  |  |  | $ | 7.86 |  |  |  |  | $ | 7.71 |  |  |
Exercise prices for options outstanding as of December 26, 2024 ranged from $12.71 to $41.90. The weighted-average remaining contractual life of those options is 5.4 years. The weighted-average remaining contractual life of options currently exercisable is 4.6 years. There were 2,868,580 options outstanding, vested and expected to vest as of December 26, 2024, with a weighted-average exercise price of $23.26 and an intrinsic value of $6,723. Additional information as of December 26, 2024 related to options outstanding segregated by exercise price range is as follows (shares in thousands):
| Exercise Price Range
| $12.71 to $17.05 |  | $17.06 to $27.00 |  | $27.01 to $41.90
Options outstanding | 1,095 |  |  | 943 |  |  | 846 |
Weighted-average exercise price of options outstanding | $ | 15.97 |  |  | $ | 22.61 |  |  | $ | 33.30 |
Weighted-average remaining contractual life of options outstanding | 7.4 |  | 4.0 |  | 4.2
Options exercisable | 422 |  |  | 857 |  |  | 846 |
Weighted-average exercise price of options exercisable | $ | 15.46 |  |  | $ | 22.70 |  |  | $ | 33.30 |
The intrinsic value of options outstanding at December 26, 2024 was $6,804 and the intrinsic value of options exercisable at December 26, 2024 was $3,155. The intrinsic value of options exercised was $725, $171 and $164 during fiscal 2024, fiscal 2023 and fiscal 2022, respectively. As of December 26, 2024, total remaining unearned compensation cost related to stock options was $1,582, which will be amortized to expense over the remaining weighted-average life of 1.8 years. Restricted Stock Awarded shares of restricted stock cumulatively vest either 25% after three years of the grant date, 50% after five years of the grant date, 75% after ten years of the grant date and 100% upon retirement, or 50% after two years of the grant date and 100% after four years of the grant date, or 50% after two years of the grant date and 100% after three years of the grant date, depending on the date of grant. A special long-term incentive and retention award of restricted stock with a vesting period of 100% after four years of the grant date, or upon retirement after three years of the grant date, was awarded to certain executives in fiscal 2024. The restricted stock may not be sold, transferred, pledged or assigned, except as provided by the vesting schedule included in the Company’s equity incentive plan. During the period of restriction, the holder of the restricted stock has voting rights and is entitled to receive all dividends and other distributions paid with respect to the stock. Restricted stock awards may be issued from previously acquired treasury shares. The Company expenses the cost of restricted stock awards over the vesting period based on the fair value of the award at the date of grant. A summary of the Company’s restricted stock activity and related information follows (shares in thousands):
| Year Ended
| December 26, 2024 |  | December 28, 2023 |  | December 29, 2022
| Shares |  | Weighted- Average Fair Value |  | Shares |  | Weighted- Average Fair Value |  | Shares |  | Weighted- Average Fair Value
Outstanding at beginning of period | 238 |  |  | $ | 17.41 |  |  | 212 |  |  | $ | 21.07 |  |  | 357 |  |  | $ | 23.32 |
Granted | 476 |  |  | 15.18 |  |  | 107 |  |  | 15.68 |  |  | 100 |  |  | 17.63 |
Vested | (47) |  |  | 21.37 |  |  | (81) |  |  | 23.77 |  |  | (242) |  |  | 22.95 |
Forfeited | — |  |  | — |  |  | — |  |  | — |  |  | (3) |  |  | 22.93 |
Outstanding at end of period | 667 |  |  | $ | 15.54 |  |  | 238 |  |  | $ | 17.41 |  |  | 212 |  |  | $ | 21.07 |
As of December 26, 2024, total remaining unearned compensation cost related to restricted stock was $4,565, which will be amortized over the weighted-average remaining service period of 2.9 years. Restricted Stock Units Restricted stock units (RSUs) cumulatively vest 50% after two years of the grant date and 100% after three years of the grant date. RSU awards are payable in common stock upon vesting. The Company expenses the cost of RSU awards over the vesting period based on the fair value of the awards at the date of grant. A summary of the Company’s RSU activity and related information follows (shares in thousands):
| RSUs
| Shares |  | Weighted- Average Fair Value
December 28, 2023 | — |  |  | $ | — |
Granted | 52 |  |  | 14.79 |
Vested | (5) |  |  | 14.84 |
Forfeited | — |  |  | — |
December 26, 2024 | 47 |  |  | $ | 14.79 |
As of December 26, 2024, total remaining unearned compensation cost related to RSUs was $500, which will be amortized over the weighted-average remaining service period of 2.2 years. Performance Stock Units Performance stock units (PSUs) vest subject to the Company’s achievement of performance goals expressed in terms of (i) earnings before interest, taxes, depreciation and amortization, or EBITDA, growth rate ranking relative to the Russell 2000 Index with respect to 25% of the total number of performance stock unit awards, and (ii) the Company’s average return on invested capital, or ROIC, ranking relative to the Russell 2000 Index with respect to 75% of the total number of performance stock unit awards. For grants awarded in fiscal 2024, the PSU performance goals relate to the three-year performance period from fiscal 2024-2026. PSU awards are payable at the end of their respective performance period in common stock, and the number of PSUs awarded can range from zero to 150% depending on the Company’s achievement of the relative performance metrics. The Company expenses the cost of PSU awards based on the fair value of the awards at the date of grant and the estimated achievement of the performance metric, ratable over the performance period of three fiscal years. A summary of the Company’s PSU activity and related information follows (shares in thousands):
| PSUs |
| Shares |  | Weighted- Average Fair Value |
December 28, 2023 | — |  |  | $ | — |  |
Granted | 143 |  |  | 14.84 |  |
Vested | — |  |  | — |  |
Forfeited | (4) |  |  | 14.84 |  |
December 26, 2024 | 139 |  |  | $ | 14.84 |  |
As of December 26, 2024, total remaining unearned compensation cost related to PSUs was $1,375, which will be amortized over the weighted-average remaining service period of 2.0 years.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/505/tableOfContent Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration